Login / Signup

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design.

Lars H LundStefan JamesAdam D DeVoreKevin J AnstromMarat FudimKeith D AaronsonUlf DahlströmPatrice Desvigne-NickensJerome L FlegSong YangMichael FuCamilla HageClaes HeldPatric KarlströmMagnus NygrenEric D PetersonTymon PolShelly SappJohan SundströmOllie ÖstlundJonas OldgrenBertram Pitt
Published in: European journal of heart failure (2024)
SPIRRIT-HFpEF will be informative on the effectiveness of generic MRAs in HFpEF and HFmrEF, and on the feasibility of conducting pragmatic and registry-based trials in heart failure and other chronic conditions.
Keyphrases
  • phase iii
  • heart failure
  • study protocol
  • phase ii
  • open label
  • randomized controlled trial
  • double blind
  • clinical trial
  • placebo controlled
  • systematic review
  • left ventricular